Indicated for combination antiretroviral treatment of HIV-1-infected patients, co-administered with 200 mg of ritonavir, who are treatment-experienced and infected with HIV-1 strains resistant to more than one protease inhibitor.

Tags: Boehringer IngelheimSupplementwellness

0.0

(0 Reviews)

5 stars
4 stars
3 stars
2 stars
1 stars

Leave a review